• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Transitions, Younger Optics team for ‘Bright Solutions’ tour

Article

Transitions and Younger Optics join to present a 15-city educational tour.

Pinellas Park, FL-Transitions Optical Inc. and Younger Optics are partnering to host the Bright Solutions city tour, set to stop in 15 cities throughout the United States. The tour will offer educational events-each worth 1 ABO credit-that explore the changing expectations of consumers and how eyecare professionals (ECPs) can meet these outlooks.

The seminar will also provide sample patient profiles and research based guidelines on the most impactful ways to recommend everyday and sunwear lenses. Additionally, ECPs will receive a complimentary trial fit voucher and tools that can help attendees grow their business.

The Bright Solutions city tour stops include:

  • May 7 – Jacksonville, FL

  • May 8 – Tampa, FL

  • May 9 – Fort Worth, TX

  • May 21 – Wilkes-Barre, PA

  • May 22 – Dallas, TX

  • June 11 – Minneapolis, MN

  • June 13 – Pittsburgh, PA

  • June 18 – Miami, FL

  • June 18 – Syracuse, NY

  • June 20 – Birmingham, AL

  • June 25 – Detroit, MI

  • July 9 – Kansas City, KS

  • July 10 – San Jose, CA

  • July 18 – Indianapolis, IN

  • July 18 – Los Angeles, CA

The Bright Solutions seminar is Florida and New York State licensed approved. Eyecare professionals can RSVP for the tour stop in their area by visiting http://transitions.com/eventrsvp, or calling 800/848-1506.

Related Videos
Charles Leclercq, CEO of ARxVision, details the new ARx AI headset and its uses
© 2024 MJH Life Sciences

All rights reserved.